- de Gonzalo Calvo, David
- Molinero, Marta
- Benítez, Iván D.
- Perez Pons, Manel
- García Mateo, Nadia
- Ortega, Alicia
- Postigo, Tamara
- García Hidalgo, María C.
- Belmonte, Thalía
- Rodríguez Muñoz, Carlos
- González, Jessica
- Torres, Gerard
- Gort Paniello, Clara
- Moncusí Moix, Anna
- Estella García, Ángel
- Tamayo Lomas, Luis
- Martínez de la Gándara, Amalia
- Socias, Lorenzo
- Peñasco, Yhivian
- de la Torre, María del Carmen
- Bustamante Munguira, Elena
- Gallego Curto, Elena
- Martínez Varela, Ignacio
- Martín Delgado, María Cruz
- Vidal Cortés, Pablo
- López Messa, Juan
- Pérez García, Felipe
- Caballero, Jesús
- Añón, José Manuel
- Loza Vázquez, Ana
- Carbonell, Nieves
- Marin Corral, Judith
- Jorge García, Ruth Noemí
- Barberà, Carmen
- Ceccato, Adrián
- Fernández Barat, Laia
- Ferrer, Ricard
- García Gasulla, Dario
- Lorente Balanza, Jose Ángel
- Menéndez, Rosario
- Motos, Ana
- Peñuelas, Oscar
- Riera, Jordi
- Bermejo Martin, Jesús F.
- Torres, Antoni
- Barbé, Ferrán
Background: The identification of critically ill COVID-19 patients at risk of fatal outcomes remains a challenge. Here, we first validated candidate microRNAs (miRNAs) as biomarkers for clinical decision-making in critically ill patients. Second, we constructed a blood miRNA classifier for the early prediction of adverse outcomes in the ICU. Methods: This was a multicenter, observational and retrospective/prospective study including 503 critically ill patients admitted to the ICU from 19 hospitals. qPCR assays were performed in plasma samples collected within the first 48 h upon admission. A 16-miRNA panel was designed based on recently published data from our group. Results: Nine miRNAs were validated as biomarkers of all-cause in-ICU mortality in the independent cohort of critically ill patients (FDR < 0.05). Cox regression analysis revealed that low expression levels of eight miRNAs were associated with a higher risk of death (HR from 1.56 to 2.61). LASSO regression for variable selection was used to construct a miRNA classifier. A 4-blood miRNA signature composed of miR-16-5p, miR-192-5p, miR-323a-3p and miR-451a predicts the risk of all-cause in-ICU mortality (HR 2.5). Kaplan‒Meier analysis confirmed these findings. The miRNA signature provides a significant increase in the prognostic capacity of conventional scores, APACHE-II (C-index 0.71, DeLong test p-value 0.055) and SOFA (C-index 0.67, DeLong test p-value 0.001), and a risk model based on clinical predictors (C-index 0.74, DeLong test-p-value 0.035). For 28-day and 90-day mortality, the classifier also improved the prognostic value of APACHE-II, SOFA and the clinical model. The association between the classifier and mortality persisted even after multivariable adjustment. The functional analysis reported biological pathways involved in SARS-CoV infection and inflammatory, fibrotic and transcriptional pathways. Conclusions: A blood miRNA classifier improves the early prediction of fatal outcomes in critically ill COVID-19 patients., 11 páginas